Neurocognitive Assessment and Rehabilitation Market Size, Share and Growth Outlook 2026: By Assessment Type (Cognitive Assessment, Behavioral Assessment, Functional Assessment), By Rehabilitation Type, By Application, By End User, Companies to 2034.
The global Neurocognitive Assessment and Rehabilitation Market size is forecast to increase from $17.1 Billion in 2026 to $34.37 Billion in 2034 at a CAGR of 9.12% between 2026 and 2034.
The Neurocognitive Assessment and Rehabilitation market report provides detailed analysis and outlook of Neurocognitive Assessment and Rehabilitation segments including By Assessment Type (Cognitive Assessment, Behavioral Assessment, Functional Assessment), By Rehabilitation Type (Cognitive Training Software, Speech and Language Therapy, Occupational Therapy, Physical Therapy), By Application (Dementia and Alzheimer's Disease, Traumatic Brain Injury (TBI), Stroke Rehabilitation, ADHD and Learning Disabilities, Multiple Sclerosis, Clinical Evaluation, Educational Settings, Research Development), By End User (Hospitals and Clinics, Research and Academic Institutes, Rehabilitation Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Neurocognitive Assessment and Rehabilitation Industry Overview
Digital Neuroassessment and Advanced Rehabilitation Technologies Are Transforming Neurological Care
The neurocognitive assessment and rehabilitation industry is experiencing substantial growth as healthcare providers increasingly focus on objective neurological evaluation, cognitive health monitoring, and technology-enabled rehabilitation interventions. Rising prevalence of stroke, traumatic brain injury, neurodegenerative disorders, Parkinson’s disease, dementia, and other central nervous system conditions is driving demand for integrated assessment and rehabilitation solutions. Healthcare organizations are adopting multidisciplinary approaches that combine digital cognitive testing, artificial intelligence, robotics, neurophysiological monitoring, and personalized rehabilitation programs to improve patient outcomes. The industry is evolving from traditional subjective assessments toward data-driven models that provide measurable insights into cognitive performance, neurological recovery, and functional rehabilitation progress. This shift is supporting broader adoption across hospitals, rehabilitation centers, specialty neurological clinics, and community healthcare settings.
Digital Cognitive Assessment Platforms Are Expanding Clinical and Research Applications
A key trend shaping the industry is the increasing adoption of digital cognitive assessment technologies capable of delivering objective and scalable evaluations. Cambridge Cognition reported significant growth in its digital cognitive assessment business, supported by strong new sales activity and expansion into professional healthcare and consumer health markets. The company strengthened its position through new agreements with a major European healthcare provider and the launch of a large-scale Brain Health Study in collaboration with OURA involving 45,000 participants. These developments highlight growing interest in digital assessment platforms that reduce administrator bias while generating standardized cognitive performance data. As healthcare systems increasingly prioritize early identification of cognitive decline, digital testing technologies are becoming valuable tools for neurological screening, longitudinal monitoring, clinical research, and population health initiatives.
AI, Robotics, and Objective Neurological Monitoring Are Advancing Rehabilitation
The rehabilitation segment is increasingly leveraging advanced technologies to improve functional recovery and personalize treatment pathways. Lupin Limited expanded its Atharv Ability neuro-rehabilitation network through the launch of a specialized center focused on patients with stroke, traumatic brain injury, Parkinson’s disease, and other neurological disorders. The facility incorporates end-effector robotic systems for gait and hand rehabilitation alongside AI-based postural control technologies, reflecting broader industry efforts to standardize technology-driven neurorehabilitation. Simultaneously, BrainScope continues to expand the application of its FDA-cleared AI-powered EEG platform, which provides objective and non-invasive neurological assessment for concussion and traumatic brain injury management. The company's ongoing development efforts are extending into central nervous system disorder classification and neurodegenerative disease monitoring. Together, these innovations demonstrate the convergence of artificial intelligence, digital biomarkers, robotics, and cognitive analytics, creating a more precise and personalized framework for neurocognitive assessment and neurological rehabilitation.
Neurocognitive Assessment and Rehabilitation Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Neurocognitive Assessment and Rehabilitation market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Cambridge Cognition Ltd, Cogstate Ltd., CogniFit Inc., Posit Science Corporation (BrainHQ), Cognetivity Neurosciences Ltd, BrainCheck, Inc., Clario, Altoida, Inc., Lumos Diagnostics Holdings, Pearson PLC. The Neurocognitive Assessment and Rehabilitation market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Neurocognitive Assessment and Rehabilitation industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Neurocognitive Assessment and Rehabilitation industry include- Cambridge Cognition Ltd, Cogstate Ltd., CogniFit Inc., Posit Science Corporation (BrainHQ), Cognetivity Neurosciences Ltd, BrainCheck, Inc., Clario, Altoida, Inc., Lumos Diagnostics Holdings, Pearson PLC. The Neurocognitive Assessment and Rehabilitation market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Neurocognitive Assessment and Rehabilitation Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Neurocognitive Assessment and Rehabilitation market remains one of the strongest-performing segments in the country.
The US Neurocognitive Assessment and Rehabilitation Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Neurocognitive Assessment and Rehabilitation market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Neurocognitive Assessment and Rehabilitation industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Neurocognitive Assessment and Rehabilitation markets
Canada's strong Neurocognitive Assessment and Rehabilitation sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Neurocognitive Assessment and Rehabilitation market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Neurocognitive Assessment and Rehabilitation Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Neurocognitive Assessment and Rehabilitation market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Neurocognitive Assessment and Rehabilitation population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Neurocognitive Assessment and Rehabilitation industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Neurocognitive Assessment and Rehabilitation market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Neurocognitive Assessment and Rehabilitation sales through 2034
France Neurocognitive Assessment and Rehabilitation companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Neurocognitive Assessment and Rehabilitation Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Neurocognitive Assessment and Rehabilitation distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Neurocognitive Assessment and Rehabilitation Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Neurocognitive Assessment and Rehabilitation market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Neurocognitive Assessment and Rehabilitation industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Neurocognitive Assessment and Rehabilitation industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Neurocognitive Assessment and Rehabilitation Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Neurocognitive Assessment and Rehabilitation market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Neurocognitive Assessment and Rehabilitation market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Neurocognitive Assessment and Rehabilitation Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Neurocognitive Assessment and Rehabilitation Market Segmentation
By Assessment Type
Cognitive Assessment
Behavioral Assessment
Functional Assessment
By Rehabilitation Type
Cognitive Training Software
Speech and Language Therapy
Occupational Therapy
Physical Therapy
By Application
Dementia and Alzheimer's Disease
Traumatic Brain Injury (TBI)
Stroke Rehabilitation
ADHD and Learning Disabilities
Multiple Sclerosis
Clinical Evaluation
Educational Settings
Research Development
By End User
Hospitals and Clinics
Research and Academic Institutes
Rehabilitation Centers
Leading Companies in Neurocognitive Assessment and Rehabilitation Industry (2026)
Cambridge Cognition Ltd
Cogstate Ltd.
CogniFit Inc.
Posit Science Corporation (BrainHQ)
Cognetivity Neurosciences Ltd
BrainCheck, Inc.
Clario
Altoida, Inc.
Lumos Diagnostics Holdings
Pearson PLC
Countries Included
The Neurocognitive Assessment and Rehabilitation market report provides detailed analysis and outlook of Neurocognitive Assessment and Rehabilitation segments including By Assessment Type (Cognitive Assessment, Behavioral Assessment, Functional Assessment), By Rehabilitation Type (Cognitive Training Software, Speech and Language Therapy, Occupational Therapy, Physical Therapy), By Application (Dementia and Alzheimer's Disease, Traumatic Brain Injury (TBI), Stroke Rehabilitation, ADHD and Learning Disabilities, Multiple Sclerosis, Clinical Evaluation, Educational Settings, Research Development), By End User (Hospitals and Clinics, Research and Academic Institutes, Rehabilitation Centers) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Neurocognitive Assessment and Rehabilitation Industry Overview
Digital Neuroassessment and Advanced Rehabilitation Technologies Are Transforming Neurological Care
The neurocognitive assessment and rehabilitation industry is experiencing substantial growth as healthcare providers increasingly focus on objective neurological evaluation, cognitive health monitoring, and technology-enabled rehabilitation interventions. Rising prevalence of stroke, traumatic brain injury, neurodegenerative disorders, Parkinson’s disease, dementia, and other central nervous system conditions is driving demand for integrated assessment and rehabilitation solutions. Healthcare organizations are adopting multidisciplinary approaches that combine digital cognitive testing, artificial intelligence, robotics, neurophysiological monitoring, and personalized rehabilitation programs to improve patient outcomes. The industry is evolving from traditional subjective assessments toward data-driven models that provide measurable insights into cognitive performance, neurological recovery, and functional rehabilitation progress. This shift is supporting broader adoption across hospitals, rehabilitation centers, specialty neurological clinics, and community healthcare settings.
Digital Cognitive Assessment Platforms Are Expanding Clinical and Research Applications
A key trend shaping the industry is the increasing adoption of digital cognitive assessment technologies capable of delivering objective and scalable evaluations. Cambridge Cognition reported significant growth in its digital cognitive assessment business, supported by strong new sales activity and expansion into professional healthcare and consumer health markets. The company strengthened its position through new agreements with a major European healthcare provider and the launch of a large-scale Brain Health Study in collaboration with OURA involving 45,000 participants. These developments highlight growing interest in digital assessment platforms that reduce administrator bias while generating standardized cognitive performance data. As healthcare systems increasingly prioritize early identification of cognitive decline, digital testing technologies are becoming valuable tools for neurological screening, longitudinal monitoring, clinical research, and population health initiatives.
AI, Robotics, and Objective Neurological Monitoring Are Advancing Rehabilitation
The rehabilitation segment is increasingly leveraging advanced technologies to improve functional recovery and personalize treatment pathways. Lupin Limited expanded its Atharv Ability neuro-rehabilitation network through the launch of a specialized center focused on patients with stroke, traumatic brain injury, Parkinson’s disease, and other neurological disorders. The facility incorporates end-effector robotic systems for gait and hand rehabilitation alongside AI-based postural control technologies, reflecting broader industry efforts to standardize technology-driven neurorehabilitation. Simultaneously, BrainScope continues to expand the application of its FDA-cleared AI-powered EEG platform, which provides objective and non-invasive neurological assessment for concussion and traumatic brain injury management. The company's ongoing development efforts are extending into central nervous system disorder classification and neurodegenerative disease monitoring. Together, these innovations demonstrate the convergence of artificial intelligence, digital biomarkers, robotics, and cognitive analytics, creating a more precise and personalized framework for neurocognitive assessment and neurological rehabilitation.
Neurocognitive Assessment and Rehabilitation Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Neurocognitive Assessment and Rehabilitation market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Cambridge Cognition Ltd, Cogstate Ltd., CogniFit Inc., Posit Science Corporation (BrainHQ), Cognetivity Neurosciences Ltd, BrainCheck, Inc., Clario, Altoida, Inc., Lumos Diagnostics Holdings, Pearson PLC. The Neurocognitive Assessment and Rehabilitation market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Neurocognitive Assessment and Rehabilitation industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Neurocognitive Assessment and Rehabilitation Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Neurocognitive Assessment and Rehabilitation companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Neurocognitive Assessment and Rehabilitation markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Neurocognitive Assessment and Rehabilitation industry include- Cambridge Cognition Ltd, Cogstate Ltd., CogniFit Inc., Posit Science Corporation (BrainHQ), Cognetivity Neurosciences Ltd, BrainCheck, Inc., Clario, Altoida, Inc., Lumos Diagnostics Holdings, Pearson PLC. The Neurocognitive Assessment and Rehabilitation market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Neurocognitive Assessment and Rehabilitation Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Neurocognitive Assessment and Rehabilitation market remains one of the strongest-performing segments in the country.
The US Neurocognitive Assessment and Rehabilitation Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Neurocognitive Assessment and Rehabilitation market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Neurocognitive Assessment and Rehabilitation industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Neurocognitive Assessment and Rehabilitation markets
Canada's strong Neurocognitive Assessment and Rehabilitation sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Neurocognitive Assessment and Rehabilitation market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Neurocognitive Assessment and Rehabilitation Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Neurocognitive Assessment and Rehabilitation market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Neurocognitive Assessment and Rehabilitation population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Neurocognitive Assessment and Rehabilitation industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Neurocognitive Assessment and Rehabilitation market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Neurocognitive Assessment and Rehabilitation sales through 2034
France Neurocognitive Assessment and Rehabilitation companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Neurocognitive Assessment and Rehabilitation Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Neurocognitive Assessment and Rehabilitation distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Neurocognitive Assessment and Rehabilitation Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Neurocognitive Assessment and Rehabilitation market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Neurocognitive Assessment and Rehabilitation industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Neurocognitive Assessment and Rehabilitation industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Neurocognitive Assessment and Rehabilitation Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Neurocognitive Assessment and Rehabilitation market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Neurocognitive Assessment and Rehabilitation market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Neurocognitive Assessment and Rehabilitation Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Neurocognitive Assessment and Rehabilitation Market Segmentation
By Assessment Type
Cognitive Assessment
Behavioral Assessment
Functional Assessment
By Rehabilitation Type
Cognitive Training Software
Speech and Language Therapy
Occupational Therapy
Physical Therapy
By Application
Dementia and Alzheimer's Disease
Traumatic Brain Injury (TBI)
Stroke Rehabilitation
ADHD and Learning Disabilities
Multiple Sclerosis
Clinical Evaluation
Educational Settings
Research Development
By End User
Hospitals and Clinics
Research and Academic Institutes
Rehabilitation Centers
Leading Companies in Neurocognitive Assessment and Rehabilitation Industry (2026)
Cambridge Cognition Ltd
Cogstate Ltd.
CogniFit Inc.
Posit Science Corporation (BrainHQ)
Cognetivity Neurosciences Ltd
BrainCheck, Inc.
Clario
Altoida, Inc.
Lumos Diagnostics Holdings
Pearson PLC
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Neurocognitive Assessment and Rehabilitation Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Neurocognitive Assessment and Rehabilitation Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Neurocognitive Assessment and Rehabilitation Markets in 2026
3.2. Global Historic and Forecast Neurocognitive Assessment and Rehabilitation Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Neurocognitive Assessment and Rehabilitation Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Neurocognitive Assessment and Rehabilitation Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Neurocognitive Assessment and Rehabilitation Value Chain
CHAPTER 4- NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Neurocognitive Assessment and Rehabilitation Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Assessment Type
Cognitive Assessment
Behavioral Assessment
Functional Assessment
By Rehabilitation Type
Cognitive Training Software
Speech and Language Therapy
Occupational Therapy
Physical Therapy
By Application
Dementia and Alzheimer's Disease
Traumatic Brain Injury (TBI)
Stroke Rehabilitation
ADHD and Learning Disabilities
Multiple Sclerosis
Clinical Evaluation
Educational Settings
Research Development
By End User
Hospitals and Clinics
Research and Academic Institutes
Rehabilitation Centers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Neurocognitive Assessment and Rehabilitation Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
7.5. North America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
7.6. North America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
7.7. North America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Neurocognitive Assessment and Rehabilitation Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Neurocognitive Assessment and Rehabilitation Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 8- EUROPE NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Neurocognitive Assessment and Rehabilitation Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
8.5. Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
8.6. Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
8.7. Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Neurocognitive Assessment and Rehabilitation Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Neurocognitive Assessment and Rehabilitation Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Neurocognitive Assessment and Rehabilitation Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Neurocognitive Assessment and Rehabilitation Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Neurocognitive Assessment and Rehabilitation Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 9- ASIA PACIFIC NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
9.6. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
9.7. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Neurocognitive Assessment and Rehabilitation Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Neurocognitive Assessment and Rehabilitation Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Neurocognitive Assessment and Rehabilitation Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Neurocognitive Assessment and Rehabilitation Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Neurocognitive Assessment and Rehabilitation Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Neurocognitive Assessment and Rehabilitation Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
10.5. South and Central America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
10.6. South and Central America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
10.7. South and Central America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Neurocognitive Assessment and Rehabilitation Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Neurocognitive Assessment and Rehabilitation Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
11.6. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
11.7. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Neurocognitive Assessment and Rehabilitation Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Neurocognitive Assessment and Rehabilitation Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Neurocognitive Assessment and Rehabilitation Industry
Cambridge Cognition Ltd
Cogstate Ltd.
CogniFit Inc.
Posit Science Corporation (BrainHQ)
Cognetivity Neurosciences Ltd
BrainCheck, Inc.
Clario
Altoida, Inc.
Lumos Diagnostics Holdings
Pearson PLC
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Neurocognitive Assessment and Rehabilitation Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Neurocognitive Assessment and Rehabilitation Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Neurocognitive Assessment and Rehabilitation Markets in 2026
3.2. Global Historic and Forecast Neurocognitive Assessment and Rehabilitation Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Neurocognitive Assessment and Rehabilitation Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Neurocognitive Assessment and Rehabilitation Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Neurocognitive Assessment and Rehabilitation Value Chain
CHAPTER 4- NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Neurocognitive Assessment and Rehabilitation Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Assessment Type
Cognitive Assessment
Behavioral Assessment
Functional Assessment
By Rehabilitation Type
Cognitive Training Software
Speech and Language Therapy
Occupational Therapy
Physical Therapy
By Application
Dementia and Alzheimer's Disease
Traumatic Brain Injury (TBI)
Stroke Rehabilitation
ADHD and Learning Disabilities
Multiple Sclerosis
Clinical Evaluation
Educational Settings
Research Development
By End User
Hospitals and Clinics
Research and Academic Institutes
Rehabilitation Centers
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Neurocognitive Assessment and Rehabilitation Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
7.5. North America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
7.6. North America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
7.7. North America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Neurocognitive Assessment and Rehabilitation Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Neurocognitive Assessment and Rehabilitation Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 8- EUROPE NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Neurocognitive Assessment and Rehabilitation Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
8.5. Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
8.6. Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
8.7. Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Neurocognitive Assessment and Rehabilitation Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Neurocognitive Assessment and Rehabilitation Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Neurocognitive Assessment and Rehabilitation Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Neurocognitive Assessment and Rehabilitation Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Neurocognitive Assessment and Rehabilitation Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 9- ASIA PACIFIC NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
9.6. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
9.7. Asia Pacific Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Neurocognitive Assessment and Rehabilitation Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Neurocognitive Assessment and Rehabilitation Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Neurocognitive Assessment and Rehabilitation Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Neurocognitive Assessment and Rehabilitation Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Neurocognitive Assessment and Rehabilitation Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Neurocognitive Assessment and Rehabilitation Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
10.5. South and Central America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
10.6. South and Central America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
10.7. South and Central America Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Neurocognitive Assessment and Rehabilitation Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Neurocognitive Assessment and Rehabilitation Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 11- MIDDLE EAST AND AFRICA NEUROCOGNITIVE ASSESSMENT AND REHABILITATION MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook by Type
11.6. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook by Application
11.7. Middle East and Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Neurocognitive Assessment and Rehabilitation Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Neurocognitive Assessment and Rehabilitation Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Neurocognitive Assessment and Rehabilitation Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Neurocognitive Assessment and Rehabilitation Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Neurocognitive Assessment and Rehabilitation Industry
Cambridge Cognition Ltd
Cogstate Ltd.
CogniFit Inc.
Posit Science Corporation (BrainHQ)
Cognetivity Neurosciences Ltd
BrainCheck, Inc.
Clario
Altoida, Inc.
Lumos Diagnostics Holdings
Pearson PLC
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
